TransCode Therapeutics, Inc. (RNAZ)
1.86
+0.15
(+8.77%)
USD |
NASDAQ |
Oct 09, 16:00
1.895
+0.04
(+1.88%)
After-Hours: 20:00
TransCode Therapeutics Market Cap : 1.882M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.882M |
| October 08, 2026 | 1.730M |
| October 07, 2026 | 1.780M |
| October 06, 2026 | 1.801M |
| October 05, 2026 | 1.780M |
| October 02, 2026 | 1.588M |
| October 01, 2026 | 1.563M |
| September 30, 2026 | 1.700M |
| September 29, 2026 | 1.649M |
| September 28, 2026 | 1.730M |
| September 25, 2026 | 1.710M |
| September 24, 2026 | 1.669M |
| September 23, 2026 | 1.700M |
| September 22, 2026 | 1.790M |
| September 21, 2026 | 1.780M |
| September 18, 2026 | 1.669M |
| September 17, 2026 | 1.74M |
| September 16, 2026 | 1.700M |
| September 15, 2026 | 1.619M |
| September 14, 2026 | 1.669M |
| September 11, 2026 | 1.710M |
| September 10, 2026 | 1.710M |
| September 09, 2026 | 1.801M |
| September 08, 2026 | 1.912M |
| September 04, 2026 | 2.084M |
| Date | Value |
|---|---|
| September 03, 2026 | 2.18M |
| September 02, 2026 | 2.033M |
| September 01, 2026 | 2.084M |
| August 31, 2026 | 2.124M |
| August 28, 2026 | 2.205M |
| August 27, 2026 | 2.306M |
| August 26, 2026 | 2.367M |
| August 25, 2026 | 2.559M |
| August 24, 2026 | 2.731M |
| August 21, 2026 | 2.903M |
| August 20, 2026 | 3.004M |
| August 19, 2026 | 3.247M |
| August 18, 2026 | 3.278M |
| August 17, 2026 | 3.197M |
| August 14, 2026 | 3.318M |
| August 13, 2026 | 3.520M |
| August 12, 2026 | 3.409M |
| August 11, 2026 | 3.145M |
| August 10, 2026 | 3.558M |
| August 07, 2026 | 3.631M |
| August 06, 2026 | 3.916M |
| August 05, 2026 | 3.897M |
| August 04, 2026 | 4.081M |
| August 03, 2026 | 3.870M |
| July 31, 2026 | 4.182M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.856B |
| Oncolytics Biotech, Inc. | 69.42M |
| Sangamo Therapeutics, Inc. | 61.22M |
| Sarepta Therapeutics, Inc. | 1.885B |
| Anixa Biosciences, Inc. | 100.30M |
Market Cap Related Metrics
| Price | 1.86 |
| Earnings Yield | -2.73K% |